丹麦的医疗保健系统必须满足每个公民对医疗保健易于获取和平等的需求。然而，调查显示癌症患者的不公正优先考虑以及针对昂贵药物而非关怀的不公平分配资源。我们需要有关适当优先考虑的原则。本文研究了美国伦理学家汤姆·鲍查姆普和詹姆斯·奇尔德雷斯公正原则作为一个概念框架对丹麦医疗保健系统中昂贵生物疗法的优先考虑进行反思的方法是否有帮助。我们进行了一项实证研究，探讨了对新型昂贵生物疗法进行优先考虑的原则。该研究包括对有经验的丹麦关键利益相关者进行的针对抗体疗法和昂贵药物资源优先考虑的定性访谈。鲍查姆普和奇尔德雷斯的模型仅包括政府资助的初级和急性医疗保健。根据访谈，本研究表明在丹麦的环境中，这个模型应该包括公民对政府资助的初级和急性医疗保健、昂贵药物以及其他稀缺治疗的平等获取。我们得出结论，经过略微修改，鲍查姆普和奇尔德雷斯的公正原则可能有助于对丹麦医疗保健系统中昂贵生物疗法的优先考虑进行反思的概念框架。© 2023年。作者。

The Danish healthcare system must meet the need for easy and equal access to healthcare for every citizen. However, investigations have shown unfair prioritization of cancer patients and unfair prioritization of resources for expensive medicines over care. What is needed are principles for proper prioritization. This article investigates whether American ethicists Tom Beauchamp and James Childress's principle of justice may be helpful as a conceptual framework for reflections on prioritization of expensive biological therapies in the Danish healthcare system. We present an empirical study exploring the principles for prioritizing new expensive biological therapies. This study includes qualitative interviews with key Danish stakeholders experienced in antibody therapy and prioritizing resources for expensive medicines. Beauchamp and Childress's model only covers government-funded primary and acute healthcare. Based on the interviews, this study indicates that to be helpful in a Danish context this model should include equal access for citizens to government-funded primary and acute healthcare, costly medicine, and other scarce treatments. We conclude that slightly modified, Beauchamp and Childress's principle of justice might be useful as a conceptual framework for reflections on the prioritization of expensive biological therapies in the Danish healthcare system.© 2023. The Author(s).